Active Implantable Medical Devices
Edited by
Hillol.Sarkar@ago-inc.com
Future outlook
Mauron sees the future of electronic implantables in less invasive devices with increased functionality. “Implants will be less one size fits all and more custom,” says Mauron. “A neurostimulator could be designed [to treat] one specific ailment, for instance.”
According to Diston, further integration of the functions of conventional and wireless pacemaker technology is coming. “Ultimately, leads could be eliminated completely, but further development and clinical testing will be needed,” he notes. “More widely, implants can carry out a host of other functions in addition to improving the health of people’s hearts. Major advances in neuromodulation have resulted in systems that act on the nervous system and brain to control pain and motion, eliminating the tremor in Parkinson’s patients, for example. Systems also can control a patient’s mood and help with clinical depression,” Diston continues. “We will see ever increasing uses of electronics in implants in the coming years, a result of Moore’s law by which computing power doubles every two years.”
www.emdt.co.uk/article/active-implantable-medical-devices-winning-power-struggle
ECG SoC
Cardiac disease is a major cause of death. Wearable heart
monitoring sensors could become an important tool for cardiac patients,
ensuring continuous monitoring during daily life. This is essential for an
accurate diagnosis of heart problems and for life-saving interventions.
Due to this large market potential, companies and research
institutes are developing products and research prototypes of wearable heart
monitoring sensors. The aim is to make wearable, easy-to-use and ultralow-
power (ULP) sensor systems with a long battery lifetime.
IMEC www2.imec.be
Holst Center www.holstcentre.com
Istanbul Hospital
Molecular Medicine
Genetic diagnostics can leverage the vast network of cell phones which will
www.triconference.com/Bioinformatics-Genome/
Genetic Diagnostics Using Wireless Systems for Global Health
Syed A. Hashsham, Ph.D.,
Center for Microbial Ecology, Michigan State University
Genetic diagnostics can leverage the vast network of cell phones which will
reach 1.4 billion by 2015. In this presentation, potential of low cost point of care
genetic analysis systems will be discussed. Performance data related to Gene-Z,
a hand-held gene analyzer, will be presented.
Two other devices with lower and higher level of target and sample multiplexing will
be introduced.
be introduced.
www.triconference.com/Bioinformatics-Genome/
It is a voluntary group of medical device regulators from around the world who have come together to build on the strong foundational work of the Global Harmonization Task Force on Medical Devices (GHTF), and to accelerate international medical device regulatory harmonization and convergence.click here More..........
ReplyDelete